WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹760 Cr | ₹626 Cr | ₹527 Cr | ₹489 Cr | ₹296 Cr |
What is the latest Total Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹626 Cr |
| Mar2023 | ₹527 Cr |
| Mar2022 | ₹489 Cr |
| Mar2021 | ₹296 Cr |
How is Total Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹760 Cr | 21.50 | |
| Mar2024 | ₹626 Cr | 18.73 | |
| Mar2023 | ₹527 Cr | 7.77 | |
| Mar2022 | ₹489 Cr | 65.13 | |
| Mar2021 | ₹296 Cr | - | |
Compare Total Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,846.6 Cr | 2.4% | 14.5% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 2.4% |
14.5% |
-11.9% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses